FDA Inspection
American CryoStem CorporationAmerican CryoStem Corporation – FDA Inspection, Jul 26, 2017
Record Details
This FDA Inspection record concerns American CryoStem Corporation, with an inspection on July 26, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 4c124375-e851-4560-9177-5c3c20f5f54c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1019160
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.42(b)Adequate space lacking to prevent mix-ups and contamination
- 21 CFR 211.46(c)Air filtration system lacking in production area
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.80(a)Procedures To Be in Writing
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American CryoStem Corporation
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2024 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 8, 2019 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for American CryoStem Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.